Re9lstered number: OB229467 Ch•rlty numbèr: 1152591 HAEUK (A company limiled by guarantee) UNAUDrrED TRUSTEES. REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2025
HAEUK (A ComnY Ilmited by guarantee) COMTENTS Page Ref•rene• and ¥dmlnSstratl¥• dètalls ol the eomp•ny. tts Tnwleeg and advlsers Tru•tees' report Indeptrndent e¥•mln•r's report Slalem•nt of flnancl•l tttlvltles 8018nce sh•èt Noi•x io the fln•nclal ¥tst•m•nt• 10-20
HAEUK IA ¢ompany limiled by guarantee) REFERENCE AND ADMINISTRATIVE DETAILS OF THE COMPANY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 30 SEPTEMBER 2025 Trustees Ann Marie Harding, Chair Rosemary Frances Joseph. Treasurer June Cole, Trustee Dr Timoihy Cfouch, Twslee Barrie Sidney Hurley. Trustee Simon Jererny Mumford. Trustee Iiesioned 16 May 20251 Padrnalal Gurugama (appointed 4 June 20251 Arnar QLJreshi lawinted 9 June 20251 Dana Shapiro, Trustee Company registered number 08229467 Chorlty reglstered number 1152591 Accountants GhABG LLP Chartered Tax Advisers and Afthuntants arine House 151 Western Road Haywafds Healh Wesl Sus58X RH163LH Page 1
HAEUK IA ¢ompany limited by guarantee) TRUSTEES. REPORT FOR THE YEAR ENDED 30 SEPTEMBER 2025 The Truslees presenl their annual report logether with the financial slalements ol the company for the period 1 Oclober 2024 to 30 Seplefflber 2025. The Annual report serves the purposes DI both a Trustees. rep)rt and a directors. report uader cotnpany law. The Trustees confirm Ihal the Annual reporl and financial slalernents ol the charitable ¢ompany cOMY with the current slalulory requirements. the reouirements of the charitable companys governing documenl and the piovisions of Ihe Statement of Recotnrnended Practice ISORPI applicable 10 charitie5 preparing their aiLount5 In a¢cordance with Ihe Financial Reporting Standard applicable in the UK and Repuwic ol Ireland IFRS1021 lellective 1 January 20191. Since the company qualrfies as sm*1 undei section 382 of the Companies Acl 2006, the Straiegic report required of mediLJm and large ¢offlpanies vrthr the Cornpanies Act 2006 IStrategi¢ Rerx)rt and Directors, Fleportl Regulations 2013 has been omitted. Oblecttves and activltles a. Pollcles and obleetives The main purpose (>f Ihe charity is lo promote and protect the physical and mental health ol suffer8r5 of Hereditary Angioedema in the Uniterj Kingdotn Ihrough the provision ol stspport, education practical advice and lo advance the education of the general public In all areas of the condition. In settiw objectives aFyJ plaming for actwrfies. Ihe Trustees have given ¢Jue consideralion lo general gUIdar published by the Charily Commission felating to public benefit. including Ihe guare 'Public benefit. running a charity IPB21'. b. Actlvlties undertaken to aehleve oblectlve¥ HAEUK has identifd the following a¢livilies to promole the achievemeNt of it5 objectives- To ensure the UK has Ihe highesl possible starKlards ol treatment loi HAE To provide patient advocacy and support. aTranging pen(Klic Palient Meetings, and maintaining and enhancing ihe website. To make representations on variou5 NHS consuiiation processes and to medical rxolessionals and Iheir proles510nal bodies. To commission the production and disseminaiion ol best practice documentation for the rnanagernent of HAE Page 2
HAEUK IA eompny Ibmiled by guar3nleè) TRUSTEES. AEPORT (COPINUED> FOR THE YEAR ENDED 30 SEPTEMBER 2025 Achievements a1 perfornwnce a. Revlew of actsvltles 2025 was a year of new developffients In the trealment aThY managetnent ot HAE wth a number of products goirKJ through clinical ITial arKI then the MHRA 3j NICE approval process. A long journey but wth one new treatment now approveo Iiy use in Ihe NHS. several more are In the latter slage arKI the choices for patients Continues to grow arKI improve. The CEO wa5 involved in a large number ol meetirKJs throghoUl Ihe l&si linanoal year In Iakng representations on beham of the patsent cotnmuruty. IcNJelher with gNiTrJ ewxrt a(ffte alongside several of the Trusle85. The Shared Decision Makiw "Power of Partrwship- Fyogramme lunded by Biocryst was a huge succes5 and nearly all Clin135 in the UK rK)w adopt a very p)SitNe aknIe io wothing jointly wth patients, enablirMJ patients themselves lo also feel me Involv&1 wt)en mak¢ng ch9e5 abo(rt treattnent5. The CEO s0 att&Kkd the Immunokw athy Allergy Nurses Gffjup in Bimiiryham. Visiled several dinics. visited offices ol some of the pharma¢wlKal companEs and had many Mee.rjS wth the cl1r71c Reference Group lor mMU¥10gY and Allergy. 1 Genetic Alliarte arKI Rafe Disease UK. In athjition. the CEO and Sever T¥ustees attee the HAEi ConfeTerrE in Copenhagen. the Rare Disease Day event organised by Genetic Aliance ai ihe House of Commons. arKI the European Associabon of Allergy ancl Cl+nvl Imm(&nolooy annual conleiere in GlaS(w. b. Fundralslng acti¥il•es and Income generallon The wimary swrce of IrMe remains donations from pharMaul$cal companies fdlowng Submission ol the necessary iMJsness arts lo them. Other lurKJiry irKludes FouTrJabon mernbers fyrKlrai5ing events. Flnanelal rev . Golng ¢oncern Alter makiNJ aFpTopriate eryujries. the Trustees have a reas(ble expeclation that the wfflpany has adequate re50urGe5 to continue In operabon& exisience lot ihe foreseeabk luture. For thi5 aSon. they continue to adopt the g(MW cOrern ba5LS in preparir*J Ihe Iinanr3al siatefflents. b. Atserves poll¢y It is the polw ol Ihe Tr4Jslees to Inrrta¢ a W of reseThes wfficient to cover 3 months anticipate exwxlrture At XJ September 2025 the of reserves was consisieth this lley. e. Prlnelpal lundlng Donahons from pharmaCthrt companies femairs the wimary source of fufKIl. However have secured addilional funding from a FoLtndaiion Trusi. Page 3
HAEUK IA eompany limited by grantee TRUSTEES. REPORT ICONTINUEDI FOA THE YEAR ENDED 30 SEPTEMBER 2025 Structure, go¥emanc• and management a. Constltulion HAEUK is registered as a chan.lth wpaFry limrted ty larantee arKI was sel tsp by a Memorandum of Asswaiion. 11 is exempt from the use ol Ihe rd.11tI'. b. Mh0o$ of appolntmènt or electk>n ot Trustees The management ol the company is Ihe resp)AY ol Ihe Trustees w1 are elted arKI eo.opled UFKler the terms of the Articles ol AsSocian_ Plans tor future perlods HAEUK wll conknnue to erUrage paiBIts aThl ihe ¥TrJer to fuThyrS¢ VJ, by way ol donations, SpsOrshIp, a¢ wUlarIpal giviThJ tn uder to tdefi the scoFe of rt5 lurmliwy sources. HAEUK I11 to umlate,'wcxJuce a fange ot pdoes to mIaze ts cperatiTrJ arrarvJements etc." iogeiher wlh developing a secuie data slorageifiling system. A cofflprehensNe utxlale ol its website be lina1&1, wc**irKJ lovrdrd5 a s11 memberfs only section. HAEUK wll aim to more Ihe nèuls of cliikjren armj )Ur peoF4e envsage that vrlunleers wll play an irtreasing iole in Ihis e$s. HAEUK is proposiw to exterky its InflUer arKI 5UFrAyt to patients in other parts ol lh8 Unite(l Kinodom. The trustees wll keep HAEUK'5 5 Year strateg Plan uw¥Jer revivw artl %atl. Members. liabillty The MemtErs of the Company arane conthtmfie an amounl not e¥ceed¢ng £1 10 the assels of Ihe cornpany In the event of r"r up. Page 4
IA company limited by guaranleel TRUSTEES. REPORT ICONTINUEDI FOR THE YEAR ENDEO 30 SEPTEMBEA 2025 Statemènt of Trustees, rè3ponslbi1ltS The Truslees (who are also IE (hrectors of ts rnpanY tot Ihe purty)5es of company lawl are responsible lor preparing the Tru5tees' rewxl arKJ the finarvJ stalemenls in ardafice with applicable law and United Kingth)m Accounting Stawxlards Iunrfed n9th)m GerlY Accerl AccounliTYJ Pockel. Company law rj•re$ the Trustees to eare linawKial stat8ment5 IOT each linaTh)al . Under company law. the Trustees ust nol approve the finalLI statemenls unless they are sab'sfied that Ihey give a iiue and fair view of Ihe slate of affairs ol the company and of lis i11¥j resources arKJ aFVtcaiion of resources, in¢ludirKJ its inctsme and eXlitUre, for thal PEfK)d. In preparry these linarla1 statemefits. Ihe Trustees are required lo: seleGI suitJe accounting polices ar lh them corLSiStently,' observe the melhocls and principles of Ihe Charities SORP IFRS 1021- tnake iudgments al accounting estirFFale5 ihal are reasonable and FKtheni". state vthether aFOicatde UK Accwnting StaThYards IFRS 1021 have been followed. subj'ttt io any matÈrkHI departures d15cthed a1 explaine(J In the ftnancial stalemenls.. prepare the linancial statements on the g)ing cLrtem basis unss rt is inappropriate to presume that Ihe comparty 11 cot)Iinue in business. The Tru5tee5 are re¥Xjn5ie for keeyw adequate a(xountiThJ records that are to show armj explain Ihe compary's transauions aré disclose with reasonthe accuracy at any lime the finartial wsrtion ol the company enable them lo ensure thal the finanuaj statemenls comply wth 11)e Companies Act 2006. They are also resFx>nsibl8 lor safeguardng the assets of Ihe company a¥MJ herte lor takiw reasone steps lor Ihe prevention delecb¢Jn ol IraL#Y aTrY other KrgJuLaiilies. Approved by ordw of the members of Ihe troard of Trustees on Apr 28. 2026 behaL+ by.. a1 ne on their Ann Marre Harding (Chair of Trusteesl Page 5
HAguK (A cornpany Ilmlted by guarantee) INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDEO 30 SEPTEMBER 2025 Independent examlner'$ report to the Trusleos ol {'the company.) I report to the charity Twste8s on my examination ol the ac¢ounls ol the Company lor the year ended 30 Seplember 2025. R8sponslbllltle¥ and basls of report As the Trustees ol the company land its directors lor tho purposes ol company lawl you are responsible lor the preparation ol the accounts in aecordan¢e with the requirements ol the Companies Act 20061.ihe 2006 Acl'l. aving salislied mysell that the accounts ol the company are not required to be audited under Pan 16 01 the 2006 Aci and are eligible loi independenl examinaiion, I feport in respect ol my examination ol the company's accounts carried out under section 145 01 the Charities Act 2011 Ilhe 2011 Acl'l. In carrying out my examination I have lollowe(I the Directions given by tho Charity Commission undor section 1451511bl ol the 2011 A¢1. Independent examlner's slalernent I have completed my èxamination. I conlirm that no matters have comè to my atteniion in ¢onneclion wilh Ihe examination giving me cause lo believe.. accounting iecords were not kept in respecl ol ihe company as required by section 386 01 the 2006 Aci., of the accounts do not accord with those records.. or the accounts do not comply wilh the accounting requirements ol seciion 396 01 the 2006 Act other than any requiremeni thai thè accounts give a 'iruo and lair, view which is noi a mailer considered a$ part ol an independent exarninalion.. or the accounts have not been prepared in accofdanee with the melh&Js and principles ol the Sialemeni ol Recommended Practice lor a¢coufiling and reporting by charities lapplicable to charilie5 preparing Iheir accounls in accordance with ltte Financial Reporting Standard applicabl8 in the UK and Republic ol Ireland IFRS 10211. I have no concems and have come across no other rnatters In conneciioft with the examination lo which attention should be drawn in this report In order lo enable a proper understanding ol the accounts lo be reached. This report is made solgly lo the companys Trustees. as a body, in accordance Trmth Part 4 01 the Charities IAccounis and Reportsl Regulations 2008. My work has been undenaken so that I might Slal8 lo the company's Trustees Ihose matters l am required lo siaie to Ihem in an Independent examinerfs report and lor no other purpose. To the fullest extenl permitted by law. I do not accepi or assume responsibilily lo anyone other than the company arid Ihg company's Trustees as a bcwjy, lor my wo(k oc lor this reFQrt. Signed.. Graham Hole grkn Daled.. 28 April 2026 GMBC LLP Chartered Tax Advisers and Aecounianls Marine House 151 Western Road Haywards Heath West Sussex RH16 3LH Page
HAEUK IA company limited by guarantee} ST ATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNTI FOR THE YEAR ENDED 30 SEPTEMBER 2025 Unrestrlcted lunds 2025 Total fund¥ 2025 Total lunds 2024 Notè Income from- Donalions atKI lega¢ies 102,670 102,670 73, 100 Totsl income 102,670 102,670 73, 100 Expenditure on: Charilable activities 120.280 120,280 129,363 Total •xpendSture 120,280 120,280 729,363 Net moveTnent in funds {17,610} {17,6101 (56,263) Reconclllatk)n of funds= Tolal fullds broLJghl Iofward Net tnovetnent In funds 122,291 {17,6101 122,291 117,6101 178,554 (56,263) Totsl lunds forward 104,681 104,681 122,291 The Statement of financial activities includes all gains and losses recognised in the year. The notes gn pages 10 10 20 fortn part ol these tinancial statements. Page 7
HAEUK IA company Ilmlted by guarantee) REGISTERED NUMBER: 08229467 BALANCE SHEET AS AT 30 SEPTEMBER 2025 2025 2024 Note Fixed assèts Tawble assets 2,231 2,231 Current assèts Cash at bank ar¥1 in ha1 lo935 125,604 109535 125,604 Current liabilities Credilors.. arnounts falh"rMJ thje wnthin or year {6.6381 15,544) Nel current asset# 102,897 120,060 Total assets less rren1 liabilities 104.681 122,291 Total nel assets 104,681 122,297 Ch8riiy lunds Reslricled lurKIs Unrestricted 104,681 122.291 TGtal funds 104,681 122.291 Page 8
IA company limlted by guarantee) REGISTERED NUklBER.. 08229467 BALANCE SHEET ICONTINUEDI AS AT 30 SEPTEMBER 2025 The company was entilled to exemption from audit sedion 477 of the Companies Act 2006. The memters have not required the company to obtain an audbt lof the year in question in accordance with seclK>n 476 01 Companies Act 2006. The Trustees acknowledge their responsib'lities for cOrnplng swlh the requirements of the Act with respect 10 accounting records and preparaiK)n of financial statements. The tinancial statetll8nts have been prepared in accordance with the pfovisions atplicatAe lo entilies Suect to the small companies regime. The linanaal statetnents wefe ? 2026 approved aLrthorised for issu8 by the Truslees arKI sned on their behalf by." Ann Marie Hardlng (Ghair ot Trusleesl The notes on page5 10 to 20 form part ol these financial statements. Page 9
HAEUK {A eomp•Try limited by guaranlee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2025 General Inforniatlon HAEUK Is a private company. limilecl by guararrtee. doMld in England and Wales. regislration number 08229467. The registered charity number is 1152591. The registered orfice of the company Is 2 Sheridan Close. Bndgwater, Sornerset. TA6 SSN. Accounting policies 2.1 Basls of PTeparatlon ol flnanclal statements The financi& slalements have been prepargj In accordance with the Charities SORP IFRS 1021- Accounting Rewrting by Charilies." Stalemenl of Recommended Practice apJicable lo charities preparing thr accounts Irh accordance with Ihe FinatKial Re[M)rtI Standard applicable in the UK ano Reputlic of Ireland IFRS 1021 leffective 1 January 20191. the Financial Reporting Standard appli In the UK and Republic of Irelar¥J IFRS 1021 arwj the Companies Aci 2006. HAEUK meets the definition of a putAr betrt litY Vler FRS 102. Assets ar lsabiltties are initial recogrnsed at histortd CO or iran&iction v¥ue unks5 Otherwse slal&Y in Ihe rgkvant accounliNJ poly. 2.2 Income Ircome is rec(wtsed the company has enithment to the I)Me. rt is probable that the Irorne wll be recewed arml the amount of wwme receivAe can t* measured reliabty. 2.3 Expenditure ExperKliliJre is reCogned once Ihere is a legal or consiruthNe otAwJation to transfer economic benefil to a Ihird party. rt Is probable Ihat a transler of ecorK)mK benefits wlll be required ITr settlemeni aThJ the amoijnt of the obligation can tye measured reliably. Expendilure s arLounted for on an awwals basis arKI has tMn Inded L%TrJer expense cèlegoriès that aregate all costs for l(10n io actIties. Expendilure on charilable aclmties is iUrred on direciiy urKlertaking ttE activitlg5 which further Ihe company s objectNes. as well as any assoTrat•Y suFwt cosls. All eXpeThjilu is itluswe of ivrecoverable VAT. Page 10
HAEUK {A company limited by guaranteè) NOTES TO THE FIPIANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2025 Accounling policies Icontinwll 2.4 Tangible Ilxed assets arKI IPreCiatIon Tangle fixed assets costiThJ £10) w more are carAtalised arKJ recognisaj when luture ecorbomic benefrts are wobaNe arxl ihe cost or vdue ol tr assel can tre measured rely. Tangle fixed assets are Initialty fec(wJn15ed at C05t. After recognition. UE*er Ihe cosl model, tangible lixed a5se15 are measvred al 51 le55 accufflulaled depreciation and any acGumulated Impairmerrt losses. All costs incurre(I to bring a tsTu"tle fixed asset inio Ils interKJed wothing coThJition should be ificluded in Ihe measkjremeni of cosi. Depreciation is charged so as lo all¢xate the wst of I1)1? fixaj assets less Iheir resldual value ¢)ver their estimated useful lryes. on a reducsrMJ bance bags Oepreciaiion is wovKl&J the fdbw"r•J bas. Othce equiwe 2.5 Cash at bank and in hand Cash al bank ar in harKJ includes cash aFKJ short-tenn tt#Jhly I#>J irwesffiients with a 5h¢yt malurity ol three tnonths (x $S IrLMn the dale of acojiglion or orpn4ng ol tt)e deposit or similar account. 2.6 Liabilttle¥ and provislon8 Lfrkn"lrties are reuNJntsed when Ihere an at Ihe BaLae she8t date as a resutt of a past eveni. rt is prObae that a Iransler ol econom nefit wll be required in sethement. a1 the amounl of the settlemenl can be estimated l&ly. Liats"libes are rec(MJnssÈd at the amount that the company antKJpaies It wll pay to selllÈ ts dgbt the amoLJnt it ha5 recewed as atha) paymenis IC the 01 servw it must prowde. Prowsions are measur•J at the estimate ol the amounis r&]uired to settle the obligation. Where the eftect of the tirne value of morey L8 material. the w0vis is based on the present value of those amounts, &scounied at the we-tax th"scouni raie thai rellects the risks specific to the liability. The unwindiro of the discount is re(xwIa in the Slalernent ol tinarKial activthes as a tinance cost. Page11
HAEUK IA cOmpY limlltd by gu•rnnteel NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30SEPTEMBER 2025 Aceountlng polbclèx Icontlnutdl 2.7 Flnancl•l I1Ment5 The company On has IarKa1 assels aTh1 finartl liablilbes of a kirKI thai qlbalrfy as ba$1¢ financial in5trurnenls Bas financial Inslruments are inibalty recogniseLI al tTansactK)n v&ue subsequenlly measured at thwr seluement Val th Ihe exceplK)n ol bank loans which are subsequenlly mgasured at amortt50d cosl Ihe elfecXNo interest method. 2.8 Fund •ceountlng G¢nèral funds Unrestr6 fun(Is a available lor use at tha discretion ol the Trustees in lurtherance ol the general C4e¢t1v of t ccrfnpany athj which have nol bgen ddald lof Olher PUfrAJse5. Page 12
HAEUK IA company limed by guarantee) NOTES TO THE FIP4ANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2025 Unrestrl¢t tuTh1s 2025 Total lunds 2025 Tolal funds 2024 Donatlon* CSL Behiing The Anderson FourKlation Kalvisia PharmaceutuLs HAE International Biocrysl Phafmaceulrds UThversity Hosprfal Bwrnryharn 30.375 16,5 iO.OLKJ 32,285 10,6 30.375 16.5fy) 10. 32.285 10,6fy) 16.500 17,428 20. 150 13.030 Sublotsl d•l•llpd dl•clowro 99.780 99.760 67, 108 Donatlons 2,910 2.910 5,992 Sublot•l 2,910 2.910 5,992 Toi•l 2025 102.670 102,670 73, 100 Total 2024 73. 100 73, 100 P13
HAEUK (A company limlted by guarantee) P40TES TO THE FINANCIAL STATEIAEPffS FOFI THE YEAR ENDED 30 SEPTEMBER 2025 Analysis of expendlture ¢)n ¢haritable activitles Summary by lund type lutKIs 2025 Tolal 2025 Total 2024 SLtw)rt and educatKm to hety) sufferers ol H8redrtary AThJoedema In the UK 120,280 120.2 129.363 Tota12024 129.363 129,363 Anatysis of expendilure by acilvllles Acllvftles undertaken dlre¢tly 21r25 Support coJ15 Total tunds 2025 Total funds 2024 2025 Support and education to he) SullerS ol Hereclrtary Aw)&Yema in the UK 32.857 87.622 120.279 129.363 Total 2024 39.2C6 90, 157 129.363 Page 14
HAEUK IA company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2025 Analysls of expendllure by actiyitoes {eoThtlnu8dl Anolysls of dirtd costs Tolal fund5 2025 Tolal funds 2024 Aeiivltles 2025 Pathenl suivey cosis Virlual patient days Research into the INed eXper*r of Herajrtary Ar¥jMa Costs of activity-CafflpawJn cost Other 5.919 5,919 1,892 28,738 26,739 26,739 {1) To¢al 2025 32.657 32.657 39.206 Total 2024 39.206 39.206 Pag8 15
HAEUK IA company Ilmlled by guaranteè} NOTES TO THE FINANCIAL ST ATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2025 AnalysSs ol expendKure by a¢tivilie¥ Iconllnuedl Anatysis ol support cos1¥ Totsi funds 2025 Tora funds 2024 Actlvities 2025 Depreciation Communication costs Websile costs Postage. priniing and stationery Travel and subsistence Trwning & Seminar Subscription costs CEO consultancy fees EO oonsullancy lees sUrry expense5 Advertising & markgting ¢QSt Insurance Accountarw fees Film produc150n IT software and consumables Design services 446 431 558 431 2.118 2,118 5,Q46 2.713 8,684 772 4.B13 466 4,B13 466 Y.489 36,575 15, 180 316 45.380 14,855 524 45,380 14,855 524 14.644 201 14.644 201 1.302 1.302 1,421 16,605 971 820 50 820 Total 2025 87.622 87,622 90, 157 Total 2(124 90. 157 90. 157 Independeni examiner'$ rèmuneratlon 2025 2024 Fees payable to the company's independent examiner lor the independenl examination of Ihe ¢ompany'5 annual accoun15 Fees payable to th8 company's independeni examiner in reswl of.. All other services not included above 318 Page 16
HAEUK IA company Ilmiied by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30SEPTEMBER 2025 Trustees. remuneration and expense$ During the year. Trustees received any rernunerab.on or other benefits (2024 - £NIL?. During Ihe year ended 30 Seplembei 2025. expenses iolalliog £1.260 were reimbursed or paid directly to 3 Tiuslees. The exn5$ felated io travel cost and HAE suNey cost. Tangible fixed assets Offlce equlpment Cost or valuatioft At l October 2024 ,711 At 30 Seplefflber 2025 8,711 Depreciation Al l October 2024 Charge for the year 6,480 446 At 30 Swember 2025 6,926 Net book value At 30 Sepiember 2025 1.785 At 30 Swember2024 2,230 Page17
HAEUK (A conyAny limited by guoranteel NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30SEPTEMBER 2025 Credltors: Amounts f•lling due wlthln OM year 2025 2024 Accru5 arKI delerred irthme 5.544 10. Flnaneial instruments 2025 2024 Financial assets Finanoal assets measured at amortised cx)51 109,535 125,604 2025 2024 Financial liabilltles Financ l*ililies mea9Jrj at am(v1iswJ cost {6.6381 {5,5441 Financial assets measured at aMSe cosi ci)mw"ses cash at bank a1 in hand. Financial liatslities measured at amortisl cost 0)mprS aczruajs. Page 18
HAEUK (A comp•ny limiled by gwr•nie¢l NOTES TO THE FINANCIAL ST ATEMENTS FOR THE YEAR ENDEO 30 SEPTEMBER 2025 Stalement of lunds Slal•ment of tunds- current year Balance at 30 Soptèmber 2025 B•lpnce •t 1 October 2024 IneoTh ExpenOllur• Vnrtstri¢t lund• Gera1 . all luThls 122.291 102,670 {120.2801 104.681 Sl•tement of lund*- prfor y••r Balance al 30 Septernb 2024 8alarte ai l (lotsel 2023 Iorne Exponthtur8 Unrestrtet•d funds General Fu3 . all luThJs 778.554 73, yLiI (129,363) 122,291 Page19
HAEUK IA compgny lirnited by guarnniÈÈ) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2025 12. Analysis of net assets between funds Anatysls 01 net assets between funds. curyenl year Unrestricted lunds 2025 Total lunds 2025 TangibTe lixed assèts Current as5eEs C¥edrtors due thIft e year 1.784 1,784 109.535 16.6381 109.535 16.6381 Totsi 104.681 104.681 Analysls of nel assets belween tunds- wlor year Unreslricted funds 2024 Totaj funds 2024 Tangible fixed assets Currenl assets Creért¢ys due Ynlhin one yeaT 2.231 2.231 125.604 15,544} 125.604 15.5441 Totsl 122,291 122,291 Page 20